Digital reminiscence therapy for seniors with Alzheimer's
Psychological and Mental Health of Institutionalized People Over 60 Years of Age With Alzheimer's: Effects of a Digital and Interactive Reminiscence Program.
This study is trying out a new digital therapy to help seniors with Alzheimer's share their memories and feel better emotionally while living in care facilities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Jaén Academic / other |
| Locations | 1 site (Jaén) |
| Trial ID | NCT06666075 on ClinicalTrials.gov |
What this trial studies
This intervention utilizes digital tools to enhance the psychological health of seniors with Alzheimer's disease living in institutions. By facilitating the sharing of personal memories and experiences, it aims to foster social interaction and emotional engagement. The approach combines technology with therapeutic reminiscence techniques to stimulate cognitive function and improve mood, potentially alleviating symptoms of anxiety and depression. Caregivers can customize content based on individual preferences, enhancing connections to the past and current social interactions.
Who should consider this trial
Good fit: Ideal candidates are individuals over 60 with a confirmed diagnosis of mild to moderate Alzheimer's who can interact with digital tools.
Not a fit: Patients with advanced Alzheimer's or other neurological conditions that impair memory or interaction with technology may not benefit from this therapy.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the quality of life and emotional well-being of seniors with Alzheimer's.
How similar studies have performed: Previous studies on reminiscence therapy have shown positive outcomes, suggesting that this digital approach may also be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * People over 60 years of age. * Confirmed diagnosis of mild or moderate Alzheimer's, where the patient still retains a certain degree of autobiographical memory. * People institutionalized in a geriatric care center or similar. * Level of cognitive impairment that allows understanding and basic interaction with digital tools. * Approval and signature of informed consent by the participant or his/her legal representative, demonstrating agreement to participate in the study. * Availability or access to devices (tablets or computers) provided by the study program or the care center. Exclusion Criteria: * Diagnosis of other neurological or psychiatric conditions (such as vascular dementia, Parkinson's, or psychotic disorders) that may significantly interfere with the program's results. * Patients in advanced stages of Alzheimer's with severe limitations in remembering autobiographical events or interacting with digital devices. * Vision, hearing, or fine motor problems that prevent the use of electronic devices in an appropriate manner, without the possibility of adaptation or assistance. * Individuals or legal representatives who are unable or unwilling to give informed consent. * Behaviors that may put the participant, staff, or other residents at risk when carrying out program activities.
Where this trial is running
Jaén
- Miguel Ángel Fernández Sevilla — Jaén, Spain (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.